vs

Side-by-side financial comparison of Esquire Financial Holdings, Inc. (ESQ) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $40.5M, roughly 1.9× Esquire Financial Holdings, Inc.). Esquire Financial Holdings, Inc. runs the higher net margin — 30.2% vs 7.4%, a 22.8% gap on every dollar of revenue. Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 15.0%).

Esquire Financial Holdings, Inc. is a U.S.-headquartered bank holding company that provides comprehensive commercial and consumer banking products and services. Its core offerings include deposit accounts, business loans, mortgage services, and wealth management solutions, primarily serving small to medium enterprises, legal industry professionals, and local retail clients.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

ESQ vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.9× larger
VMD
$76.2M
$40.5M
ESQ
Higher net margin
ESQ
ESQ
22.8% more per $
ESQ
30.2%
7.4%
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
15.0%
ESQ

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ESQ
ESQ
VMD
VMD
Revenue
$40.5M
$76.2M
Net Profit
$12.2M
$5.6M
Gross Margin
57.9%
Operating Margin
11.0%
Net Margin
30.2%
7.4%
Revenue YoY
25.5%
Net Profit YoY
7.0%
30.7%
EPS (diluted)
$1.40
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESQ
ESQ
VMD
VMD
Q1 26
$40.5M
Q4 25
$39.4M
$76.2M
Q3 25
$37.6M
$71.9M
Q2 25
$35.8M
$63.1M
Q1 25
$33.8M
$59.1M
Q4 24
$33.1M
$60.7M
Q3 24
$31.9M
$58.0M
Q2 24
$30.6M
$55.0M
Net Profit
ESQ
ESQ
VMD
VMD
Q1 26
$12.2M
Q4 25
$13.5M
$5.6M
Q3 25
$14.1M
$3.5M
Q2 25
$11.9M
$3.2M
Q1 25
$11.4M
$2.6M
Q4 24
$11.8M
$4.3M
Q3 24
$11.4M
$3.9M
Q2 24
$10.5M
$1.5M
Gross Margin
ESQ
ESQ
VMD
VMD
Q1 26
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Operating Margin
ESQ
ESQ
VMD
VMD
Q1 26
Q4 25
44.3%
11.0%
Q3 25
46.5%
7.8%
Q2 25
42.5%
8.1%
Q1 25
45.9%
6.5%
Q4 24
47.4%
10.6%
Q3 24
48.8%
9.7%
Q2 24
46.9%
6.6%
Net Margin
ESQ
ESQ
VMD
VMD
Q1 26
30.2%
Q4 25
34.2%
7.4%
Q3 25
37.4%
4.9%
Q2 25
33.2%
5.0%
Q1 25
33.8%
4.4%
Q4 24
35.6%
7.1%
Q3 24
35.6%
6.7%
Q2 24
34.3%
2.7%
EPS (diluted)
ESQ
ESQ
VMD
VMD
Q1 26
$1.40
Q4 25
$1.54
$0.14
Q3 25
$1.62
$0.09
Q2 25
$1.38
$0.08
Q1 25
$1.33
$0.06
Q4 24
$1.35
$0.10
Q3 24
$1.34
$0.10
Q2 24
$1.25
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESQ
ESQ
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$222.2M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.3M
$141.5M
Total Assets
$2.4B
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESQ
ESQ
VMD
VMD
Q1 26
$222.2M
Q4 25
$235.9M
$13.5M
Q3 25
$240.8M
$11.1M
Q2 25
$163.0M
$20.0M
Q1 25
$173.0M
$10.2M
Q4 24
$126.3M
$17.5M
Q3 24
$147.7M
$11.3M
Q2 24
$152.7M
$8.8M
Stockholders' Equity
ESQ
ESQ
VMD
VMD
Q1 26
$301.3M
Q4 25
$289.6M
$141.5M
Q3 25
$279.2M
$133.6M
Q2 25
$263.6M
$139.7M
Q1 25
$250.7M
$134.8M
Q4 24
$237.1M
$131.4M
Q3 24
$232.6M
$125.0M
Q2 24
$217.4M
$119.4M
Total Assets
ESQ
ESQ
VMD
VMD
Q1 26
$2.4B
Q4 25
$2.4B
$199.2M
Q3 25
$2.2B
$202.4M
Q2 25
$2.1B
$184.6M
Q1 25
$2.0B
$178.1M
Q4 24
$1.9B
$177.1M
Q3 24
$1.8B
$169.5M
Q2 24
$1.7B
$163.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESQ
ESQ
VMD
VMD
Operating Cash FlowLast quarter
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESQ
ESQ
VMD
VMD
Q1 26
Q4 25
$59.8M
$18.4M
Q3 25
$16.8M
$18.4M
Q2 25
$10.5M
$12.3M
Q1 25
$15.8M
$2.9M
Q4 24
$42.2M
$15.0M
Q3 24
$10.5M
$12.7M
Q2 24
$7.2M
$10.2M
Free Cash Flow
ESQ
ESQ
VMD
VMD
Q1 26
Q4 25
$56.7M
$9.7M
Q3 25
$16.2M
$10.7M
Q2 25
$9.3M
$4.1M
Q1 25
$14.7M
$-12.6M
Q4 24
$41.5M
$3.2M
Q3 24
$10.5M
$1.7M
Q2 24
$6.9M
$1.2M
FCF Margin
ESQ
ESQ
VMD
VMD
Q1 26
Q4 25
143.9%
12.7%
Q3 25
43.2%
14.9%
Q2 25
26.0%
6.5%
Q1 25
43.4%
-21.4%
Q4 24
125.5%
5.2%
Q3 24
32.8%
3.0%
Q2 24
22.5%
2.3%
Capex Intensity
ESQ
ESQ
VMD
VMD
Q1 26
Q4 25
8.0%
11.5%
Q3 25
1.3%
10.6%
Q2 25
3.2%
12.9%
Q1 25
3.4%
26.2%
Q4 24
2.2%
19.5%
Q3 24
0.2%
19.0%
Q2 24
1.1%
16.3%
Cash Conversion
ESQ
ESQ
VMD
VMD
Q1 26
Q4 25
4.44×
3.27×
Q3 25
1.19×
5.23×
Q2 25
0.88×
3.88×
Q1 25
1.39×
1.09×
Q4 24
3.59×
3.47×
Q3 24
0.93×
3.29×
Q2 24
0.69×
6.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESQ
ESQ

Net Interest Income$34.0M84%
Noninterest Income$6.5M16%

VMD
VMD

Segment breakdown not available.

Related Comparisons